GeneBioTech Co. Ltd (086060) — Cash Flow Reinvestment Rate
GeneBioTech Co. Ltd (086060) has a Cash Flow Reinvestment Rate of 0.54x as of September 2025, reinvesting ₩2.11 Billion (capex ₩194.03 Million plus investments ₩-1.91 Billion) from operating cash flow of ₩3.87 Billion. Check how high is GeneBioTech Co. Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
GeneBioTech Co. Ltd Cash Flow Reinvestment Rate (2009–2023)
Historical reinvestment intensity for GeneBioTech Co. Ltd across 11 annual periods. Explore GeneBioTech Co. Ltd long-term investment intensity to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for GeneBioTech Co. Ltd (2009–2023)
Year-by-year capital reinvestment analysis for GeneBioTech Co. Ltd. For live market cap and broader valuation context, see 086060 stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 0.83x | ₩6.09 Billion | ₩7.37 Billion | ₩766.93 Million | ▼ -73.0% |
| 2020 | 3.06x | ₩7.63 Billion | ₩2.49 Billion | ₩4.39 Billion | ▲ +216.7% |
| 2018 | 0.97x | ₩5.76 Billion | ₩5.96 Billion | ₩558.47 Million | ▼ -80.2% |
| 2017 | 4.89x | ₩5.54 Billion | ₩1.13 Billion | ₩1.11 Billion | ▲ +1014.3% |
| 2016 | 0.44x | ₩2.33 Billion | ₩5.31 Billion | ₩1.30 Billion | ▲ +3.9% |
| 2015 | 0.42x | ₩1.10 Billion | ₩2.61 Billion | ₩927.06 Million | ▲ +61.1% |
| 2014 | 0.26x | ₩565.10 Million | ₩2.15 Billion | ₩510.55 Million | ▲ +7.2% |
| 2013 | 0.24x | ₩582.01 Million | ₩2.38 Billion | ₩582.01 Million | ▼ -75.4% |
| 2011 | 0.99x | ₩2.51 Billion | ₩2.53 Billion | ₩2.51 Billion | ▲ +66.9% |
| 2010 | 0.60x | ₩693.45 Million | ₩1.17 Billion | ₩693.45 Million | ▲ +593.8% |
| 2009 | 0.09x | ₩229.99 Million | ₩2.68 Billion | ₩229.99 Million | — |